These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15211090)

  • 1. Endothelial dysfunction, inflammation and diabetes.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P
    Rev Endocr Metab Disord; 2004 Aug; 5(3):189-97. PubMed ID: 15211090
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of insulin secretagogues and insulin sensitizing agents in the prevention of cardiovascular disease in patients who have diabetes.
    Jawa AA; Fonseca VA
    Cardiol Clin; 2005 May; 23(2):119-38. PubMed ID: 15694742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes.
    Bianchi C; Miccoli R; Daniele G; Penno G; Del Prato S
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S342-8. PubMed ID: 19875578
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in atherosclerosis and diabetes mellitus.
    Plutzky J
    Rev Endocr Metab Disord; 2004 Aug; 5(3):255-9. PubMed ID: 15211097
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes mellitus. Medication update.
    Slagle M
    South Med J; 2002 Jan; 95(1):50-5. PubMed ID: 11827245
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
    Saha SA; Tuttle KR
    Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance and atherosclerosis. Controlling diabetes on 2 fronts].
    MMW Fortschr Med; 2003 Sep; 145(37):65. PubMed ID: 14584452
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on metformin - a major cardiovascular medication. 'Diabesity - the biggest epidemic in human history'.
    Straughan JL
    Cardiovasc J Afr; 2007; 18(5):331-3. PubMed ID: 17985034
    [No Abstract]   [Full Text] [Related]  

  • 12. Seeking sweet relief for diabetes.
    Dove A
    Nat Biotechnol; 2002 Oct; 20(10):977-81. PubMed ID: 12355109
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic management of diabetes mellitus.
    Mozersky RP
    J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy with biguanides].
    Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R
    Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
    [No Abstract]   [Full Text] [Related]  

  • 16. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Masbernard A; Portal A
    Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular effects of insulin sensitizers in diabetes.
    Jawa A; Fonseca V
    Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.
    Johnson JA; Majumdar SR
    Am Heart J; 2004 Dec; 148(6):e27; author reply e28. PubMed ID: 15632864
    [No Abstract]   [Full Text] [Related]  

  • 19. Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction.
    Leo CH; Woodman OL
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):532-44. PubMed ID: 25387248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetes.
    Home P
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S33-42. PubMed ID: 22650223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.